Spelling suggestions: "subject:"glucocorticoids."" "subject:"flucocorticoids.""
191 |
The Physiological Effects of Long-term UnemploymentAndersson, Maja January 2019 (has links)
The stress system is essential for humans and other organisms to survive. However, when stress is prolonged it can have pathological effects on the brain. To experience long-term unemployment is often stressful, for it has been shown to correlate with depression, low self- esteem, learned helplessness and self-destructive behavior. Long-term unemployment also seems to have physiological consequences, for it has been shown to correlate with cortisol dysregulation. The hippocampus is a highly adaptable part of the brain located in the temporal lobe and is long known for its sensitivity to cortisol dysregulation due to stress. The aim of this thesis is to study how long-term unemployment affects physical and psychological well- being, focusing in particular upon finding out whether it affects the hippocampus. The results suggest that that the kind of stress caused by long-term unemployment is similar to the stress affecting the hippocampus. It thus seems to be a reasonably hypothesis that long-term unemployment has a negative influence upon the brain, and the hippocampus in particular.However, there is an additional issue that one needs to take into account. For some studies have shown that people with poor mental health are more likely to be unemployed. If poor mental health is associated with physiological disorders (including a damaged hippocampus), this implies that not only can long-term unemployment (via stress) affect the hippocampus, but a damaged hippocampus (along with other physiological factors) can increase the probability to become unemployed. This means that the relationship between long-term unemployment and a damaged hippocampus need not be a one-way causal relationship.
|
192 |
Crosstalk of Glucocorticoid Receptor and AMP-activated protein kinase in macrophages during skeletal muscle regeneration / Interactions entre le Récepteur aux glucocorticoïdes et l'AMP-activated protein kinase dans les macrophages au cours de la régénération du muscle strié squelettiqueDesgeorges, Thibaut 22 May 2019 (has links)
Le muscle strié squelettique régénère ad integrum après une lésion aigüe stérile grâce aux cellules satellites qui sont les cellules souches du muscle strié squelettique. L'inflammation, et notamment les macrophages, joue un rôle important durant ce processus. En effet, après une lésion, les monocytes sanguins infiltrent le tissu et deviennent des macrophages avec un phénotype pro-inflammatoire associé à la lésion. Ces macrophages phagocytent les débris cellulaires et promeuvent la prolifération des cellules souches musculaires. Ensuite, les macrophages changent leur phénotype vers un phénotype anti-inflammatoire associé à la restauration du tissu. Ils promeuvent la différenciation, puis la fusion des cellules souches musculaires et la croissance des myofibres. Cette séquence de phénotypes inflammatoires est essentielle pour une régénération musculaire efficace. Le laboratoire a montré que ce changement de phénotype est dépendant d'un senseur énergétique majeur de la cellule qui contrôle le métabolisme cellulaire, l'AMP kinase (AMPK)al. Par ailleurs, les glucocorticoïdes sont utilisés depuis des décennies pour leurs effets anti-inflammatoires sur l'inflammation. Leur action est médiée par le Récepteur aux Glucocorticoïdes qui induit ou réprime l'expression de gènes par interaction directe ou indirecte à l'ADN. Comme l'AMPKal et les glucocorticoïdes induisent des effets anti-inflammatoires similaires sur les macrophages, nous avons posé l'hypothèse que ces 2 voies de signalisation pourraient être interconnectées dans les macrophages afin de permettre leur changement de phénotype et la régénération musculaire. Les données issues d'un modèle in vitro de lésion musculaire utilisant des macrophages dérivés de la moelle osseuse de souris ont montré que : i) les glucocorticoïdes induisaient la phosphorylation de l'AMPKal ; ii) l'AMPKal était requise pour l'acquisition fonctionnelle du statut anti-inflammatoire des macrophages induit par les glucocorticoïdes puisque des macrophages déficients pour l'AMPKal ne modifiaient pas leur phénotype et ne stimulaient pas la myogenèse. Les expériences in vivo utilisant des souris LysMCre/+;AMPKalfl/fl dans lesquelles l'AMPKal est invalidée uniquement dans les cellules myéloïdes ont montré que l'AMPKal dans les macrophages régulait les effets bénéfiques des glucocorticoïdes au cours de la régénération du muscle strié squelettique. En effet, en absence d'AMPKal dans les macrophages, les glucocorticoïdes induisaient un retard de régénération et une modification de la maturation des fibres attestée par une modification de l'expression des isoformes des chaînes lourdes de myosines. En conclusion, ces données montrent que l'AMPKal est requise pour le changement de phénotype des macrophages induit par les glucocorticoïdes et une régénération musculaire efficace / Skeletal muscle regenerates ad integrum after a sterile acute injury thanks to satellite cells (muscle stem cells). Inflammation, and notably macrophages, plays important roles during this process. Just after injury, monocytes infiltrate the tissue from the blood and convert into pro-inflammatory damaged associated macrophages. These macrophages phagocyte muscle debris and promote the proliferation of muscle stem cells. Then, macrophages switch their phenotype toward an anti-inflammatory restorative profile and promote muscle stem differentiation, fusion and myofiber growth. This sequence of macrophage profile is essential for an efficient skeletal muscle regeneration. The lab has shown that this phenotype switch is dependent of AMP kinase (AMPK)a1, a major energetic sensor in the cell controlling cellular metabolism. Besides, glucocorticoids have been used for decades for their anti-inflammatory effects on inflammation. Their actions are mediated by the Glucocorticoid Receptor which induces or represses gene expression by direct or indirect DNA-binding. As AMPKa1 and glucocorticoids induce similar anti-inflammatory effects on macrophages, we hypothesized that these 2 pathways could be interconnected in macrophages to allow the resolution of inflammation and muscle repair. Data from an in vitro model of skeletal muscle injury using bone marrow derived macrophages showed that: i) glucocorticoids induce AMPK phosphorylation; ii) AMPKa1 is required for the functional acquisition of the anti-inflammatory phenotype induced by glucocorticoids. Indeed, AMPKa1-deficient macrophages did not switch their phenotype and did not sustain myogenesis. In vivo experiments using LysMCre/+;AMPKa1fl/fl mice in which AMPKa1 is depleted only in myeloid cells, showed that macrophagic AMPK drove the beneficial effects of glucocorticoids during skeletal muscle regeneration. Inversely, in absence of AMPK in macrophages, glucocorticoids induced a delayed muscle regeneration and a modification in myofiber maturation, assessed by the alteration of myosin heavy chain expression. Altogether, these data show that glucocorticoids need AMPKa1 in macrophages for the resolution of inflammation and an efficient skeletal muscle regeneration
|
193 |
The effect of Predef 2X and Flucort on blood metabolites, immune function and milk composition in Holstein dairy cows /Sindhwani, Madhu Rani. January 2007 (has links)
No description available.
|
194 |
Effect of two glucocorticoid-inducible proteins on human fibroblast-like synoviocytesSampey, Annaleise,1972- January 2001 (has links)
Abstract not available
|
195 |
Mechanisms underlying glucocorticoid-induced protein wasting and potential treatment with anabolic hormonessBurt, Morton Garth, St Vincent's Clinical School, UNSW January 2007 (has links)
Protein wasting is a complication of glucocorticoid (GC) therapy. It causes substantial morbidity and there is no treatment. This thesis investigates the metabolic mechanisms underlying GC-induced protein wasting and the potential for anabolic hormones to reverse protein loss. The models of GC excess were Cushing's syndrome and GC therapy. Whole body protein metabolism was assessed using the leucine turnover technique and body composition by dual-energy X-ray absorptiometry to estimate lean body mass (LBM) and fat mass (FM). As previous studies demonstrated that LBM and FM influenced rates of protein metabolism, the magnitude of body compositional abnormality in Cushing's syndrome was determined. After accounting for the greater FM (30%) and lesser LBM (15%), protein metabolism in Cushing's syndrome was characterised by a significant increase in protein oxidation, an abnormality that leads to irreversible protein loss. Successful treatment of Cushing's syndrome normalised protein oxidation. Studies of the acute and chronic effects of therapeutic GCs revealed a time-dependent effect on protein metabolism. GCs acutely increased protein oxidation. However, the rate of protein oxidation during chronic therapy at a similar dose was not significantly different to untreated control subjects. This time-dependent change suggests that GC-induced stimulation of protein oxidation does not persist and could represent a metabolic adaptation to limit protein loss. This finding contrasts with that in Cushing's syndrome, where protein oxidation is persistently elevated. This difference may represent a dose effect. Studies in GH-deficient subjects revealed that GH induced a fall in protein oxidation that was significantly correlated with a subsequent gain in LBM. This suggests that the anabolic potential of a therapeutic substance can be predicted by its ability to suppress protein oxidation acutely. Finally, the potential for GH and androgens to reverse the metabolic effects of GCs was assessed. A preliminary study in GC users revealed that a GH dose of 0.8 mg/d was effective in reducing protein oxidation. In a subsequent study, the GH-induced reduction in protein oxidation in women on GCs was enhanced by combined treatment with dehydroepiandrosterone, an androgen. In summary, GCs induce protein loss by stimulating protein oxidation. GH reverses this effect and this action is enhanced by coadministration of androgens. GH and androgens may be used therapeutically to prevent protein loss induced by GCs.
|
196 |
Effects of glucocorticoid and phosphodiesterase-4 inhibitor therapy in a mouse model of chronic asthmaHerbert, Cristan, Medical Sciences, Faculty of Medicine, UNSW January 2007 (has links)
Asthma is a chronic inflammatory disease of the airways. Using a murine model which replicates many characteristic features of human asthma, this study evaluated the effects of treatment with anti-inflammatory drugs on the lesions of chronic asthma, and investigated potential underlying molecular mechanisms. Treatment with dexamethasone, a glucocorticoid, was compared with roflumilast, a novel phosphodiesterase-4 (PDE4) inhibitor. BALB/c mice sensitised to ovalbumin were challenged with a low mass concentration of aerosolised antigen for 30 min/day, 3 days/week for 6 weeks. In weeks 5 and 6, groups of animals were treated with either dexamethasone or roflumilast. Assessment included changes in acute-on-chronic inflammation, structural remodelling of the airways and airway hyper-responsiveness to a bronchoconstrictor stimulus. These were correlated with the expression of pro-inflammatory cytokines and growth factors. Compared to vehicle-treated control animals, dexamethasone- and roflumilast-treated mice exhibited reduced accumulation of intra-epithelial eosinophils and chronic inflammatory cells, including CD3+ T-lymphocytes in the airways. Similarly, both drugs inhibited subepithelial fibrosis and airway epithelial thickening, although only dexamethasone inhibited goblet cell hyperplasia/metaplasia. Airway hyper-reactivity was not diminished by either drug. Both treatments suppressed production of Th2 cytokines by ovalbumin-restimulated peribronchial lymph node cells. In selectively dissected airway tissue from vehicletreated animals, increased expression of mRNA for several pro-inflammatory cytokines (TNF-α, GM-CSF, IL-6) and cytokines characteristic of Th1 (IFN-γ), Th2 (IL-5, IL-13)and Th17 (IL-17A) cells was demonstrated using real-time PCR. Enhanced expression of growth factors (TGF-β1 and FGF-2) was also demonstrated in airway epithelium isolated by laser capture microdissection. Interestingly, whereas treatment with dexamethasone significantly inhibited expression of mRNA for all of the inflammationrelated cytokines examined, roflumilast inhibited only IL-17A, TNF-α, GM-CSF and IL-6. Both drugs inhibited mRNA expression of growth factors by epithelial cells. Because roflumilast was as effective as dexamethasone in suppressing inflammation and most changes of remodelling, the selective suppression of IL-17A, TNF-α, GM-CSF and IL-6 suggests that these mediators, or the cells that produce them, may have critical roles in pathogenesis. Furthermore, they may be particularly appropriate therapeutic targets in chronic asthma.
|
197 |
Inflammatory and Thrombotic Responses to Microbial Products in Fetal Vessels Are Mediated through Divergent Toll-Like Receptor Signaling Pathways: Implications in Fetal Inflammatory Response SyndromeDavarya, Shekar Ligia 11 February 2008 (has links)
Placental vessels and the umbilical circulatory network function to carry oxygen and nutrients to the fetus. It is at this level that placental lesions such as villitis, obliterative vasculopathy, and thrombotic vasculopathy have been observed in association with fetal inflammatory response syndrome (FIRS) and cerebral palsy. We used human umbilical vein endothelial cells (HUVECs) as a model to study the regulation of inflammation and thrombosis in fetal vessels by microbial products. In this thesis we measured interleukin-8 (IL-8) and tissue factor (TF) expression by HUVECs treated with lipopolysaccharide (LPS), poly (I:C) (PIC), and peptidoglycan (PG). Our results show a profound induction of IL-8 by PIC, a TLR-3 ligand. We also show a moderate induction of tissue factor expression in PIC-treated HUVECs. These results show that HUVECs are exquisitely sensitive to PIC and suggests an important role for viral infection in umbilical vessel inflammation. We additionally treated HUVECs with dexamethasone (DEX), an anti-inflammatory steroid, and melatonin (MT), a pineal gland product with immunomodulatory and anti-oxidant properties. DEX reduced the level of both IL-8 and TF expression in PIC-treated cells. MT, however, further enhanced IL-8 expression in PIC-treated cells. Our results indicate a potential role for glucocorticoid therapy in reducing placental vessel inflammation and thrombosis. Thus, intervention with GC in pregnancies with FIRS may reduce the severity of placental lesions associated with cerebral palsy.
|
198 |
The glucocorticoid responsive unit of the xenopus [gamma]fibrinogen gene requires a cooperative interaction between the glucocorticoid receptor and a novel accessory factorMorin, Brian L. January 1999 (has links)
Thesis (Ph. D.)--University of Missouri--Columbia, 1999. / Typescript. Vita. Includes bibliographical references (leaves 128-129). Also available on the Internet.
|
199 |
Dystocia in the bitch : epidemiology, aetiology and treatment /Bergström, Annika, January 2009 (has links) (PDF)
Diss. (sammanfattning) Uppsala : Sveriges lantbruksuniversitet, 2009. / Härtill 4 uppsatser.
|
200 |
Hämatologisch-immunologische Verlaufsuntersuchungen bei Kühen mit GebärpareseWinkler, Katharina Regina 11 June 2015 (has links) (PDF)
Zusammenfassung
Katharina Regina Winkler
Hämatologisch-immunologische Verlaufsuntersuchungen bei Kühen mit Gebärparese
Medizinische Tierklinik der Veterinärmedizinischen Fakultät der Universität Leipzig
Eingereicht im September 2014
100 Seiten, 41 Abbildungen, 13 Tabellen, 282 Literaturangaben, 17 Seiten Anhang
Schlüsselwörter: Gebärparese, Stoffwechsel, Glucocorticoide, Endotoxin, Blutbild
Problemstellung: Der Mineralstoffwechsel unterliegt immunologischen Einflüssen. Vitamin-D3 ist essentiell für die Antigen- und Zytokinsynthesen in den Blutzellen. Die Osteoblastenreifung wird durch Zytokine beeinflusst. Das tangiert die Gebärparese (GP) und erschließt potentiell prophylaktische sowie therapeutische Ansätze.
Zielstellung: Es wurde geprüft, ob a) es Mineralstoffunterschiede bei der GP-Diagnose und im Verlauf zu früheren Studien gibt, b) die Parameter Endotoxin (ET), anti-Lipid A-IgG-Titer (ALA-IgG-Titer) und Haptoglobin (Hp) sowie Leuko- und Erythrogramme gesicherte Beziehungen zur GP sowie zu Mineralstoffen und immunologischen Parametern haben, c) die Therapie bei GP durch Glucocorticoide verbessert werden kann und d) Jungkühe mehr Geburtsstress und Belastungen des Ca-Pi-K-Stoffwechsels haben.
Versuchsanordnung: Untersucht wurden 111 HF-Kühe bzw. Jungkühe: 21 GP-Kühe mit Grundbehandlung, 22 GP-Kühe mit zusätzlicher Dexamethason-21-iso-ni-cotinat-Therapie (Dexa-IN), 40 gesunde Kontrollkühe (KG) und 28 gesunde Jungkühe. Laborkontrollen erfolgten bei den GP-Kühen vor der Therapie, bei den KG 1 - 3 Tage post partum (d p. p.) sowie 1 d und 14 d nach dem Therapiedatum. Analysiert wurden neben Stoffwechselparametern Endotoxin (LAL-Test), ALA-IgG-Titer, Haptoglobin sowie das Leuko- und Erythrogramm.
Ergebnisse: Die Erstbehandlung war bei 47 % ohne und 67 % mit Dexa-IN-Therapie erfolgreich; die Heilungsrate betrug 74 bzw. 82 %, d. h., die Dexa-IN-Therapie verbesserte das Behandlungsergebnis bei GP ohne Nebenwirkungen.
69,8 % der GP-Kühe hatten eine kombinierte Hypokalz- und Hypophosphatämie. 24 Stunden nach Beginn der Therapie waren beide Mineralstoffe in den GP-Gruppen wieder physiologisch. 11,6 % der GP-Kühe und 10,7 % der Jungkühe hatten eine Hypophosphatämie. Das ist offensichtlich eine Folge des Kalbestresses in diesen Gruppen.
Die Mg-, Na- und Cl-Konzentrationen waren in allen Gruppen physiologisch. Mg korrelierte negativ mit Ca und Pi (p<0,01). Die K-Konzentrationen waren in den GP-Gruppen einen d p. p. signifikant niedriger als in den KG. Sie korrelierten mit Ca- und Pi in den GP-Gruppen mit 0,42 bis 0,48 (p<0,01). Auf stärkere Stresseinflüsse auf K wiesen Korrelationen zu Glucose, Bilirubin, eosinophile und basophile Granulozyten sowie Lymphozyten hin. Die Fe-Konzentrationen der GP- und KG-Kühe waren physiologisch. Fe korrelierte mit ALA-IgG-Titer gesichert negativ.
Die ET-Konzentrationen ließen nur schwache Beziehungen zur GP erkennen, wie rET:Ca=-0,17 (p<0,05). ET korrelierte mit den ALA-IgG-Titern gesichert positiv (Dexa-IN-Gruppe). Die ALA-IgG-Titer differierten bei den Kühen nicht gesichert, sie korrelierten nicht mit Ca, aber mit Pi und mit der Mehrzahl der klinisch-chemischen und hämatologischen Parameter. Das zeigt die Entzündungseinflüsse auf den Pi-Stoffwechsel mit der Förderung von Hypophosphatämien. Die Hp-Konzentrationen streuten stark und waren in allen Gruppen am Diagnose- und noch mehr am Folgetag erhöht (p>0,05). Bei Jungkühen wies der höhere Anstieg auf stärkeren Kalbestress hin.
Die Leukozytenzahl war am GP-Diagnosetag erhöht (Leukozytose; p>0,05) und sank zum Folgetag in den Normbereich ab. In der Dexa-IN-Gruppe war der Abfall am stärksten (p<0,05). Die Leukozytenzahl korrelierte gesichert negativ mit den ALA-IgG-Titer sowie in den GP-Gruppen mit den Pi- sowie Ca-Konzentrationen, ebenso die neutrophilen Granulozyten. Eosinophile, basophile Granulozyten sowie Lymphozyten sanken p. p. ab (p<0,05) und korrelierten gesichert mit Ca und Pi. Die GP-Kühe hatten am Diagnosetag eine Monozytose (p<0,05). Die Monozyten korrelierten mit den ALA-IgG-Titern, mit dem Pi und dem Ca gesichert negativ. Sie hatten die engsten Beziehungen zum Entzündungsgeschehen sowie den Pi- und Ca-Konzentrationen.
Die CK-Aktivitäten waren am Diagnose- und am Folgetag gegenüber der KG signifikant erhöht. Mit Ca korrelierte die CK in allen Kuh-Gruppen gesichert negativ, mit Pi nur in der GP-Gruppe ohne Dexa-IN. Die CK stand in enger gesicherter Beziehung zu Entzündungsindikatoren. Hämoglobin war in den GP-Gruppen am Diagnosetag signifikant, der Hämatokrit und die Erythrozytenzahlen tendenziell gesteigert.
Schlussfolgerungen: Die Studie zeigt bei GP-Kühen vielfältige Beziehungen des Ca-Pi-K-Stoffwechsels zu Entzündungsindikatoren und legt ursächliche Einflüsse nahe, besonders zu ALA-IgG-Titern und Monozyten. Sie können Ursachen für Hypophosphat- und Hypokalämie sein. Zusätzliche Dexa-IN-Therapie verbessert das Behandlungsergebnis.
|
Page generated in 0.0516 seconds